The fragile X syndrome (FXS), a type of inherited mental retardation (MR), is due to the silencing of the FMR1 X-linked gene. In over 95 percent of the cases, the mutation is due to an expansion of an unstable CGG repeat sequence located in the 5' untranslated region of the gene. Once expanded to over 200 repeats, the FMR1 gene is hypermethylated and consequently no message is transcribed. In the previous grant, the investigators suggested that, in addition to this specific mutation and resulting MR, there may also be a phenotype associated with an increased number of CGG repeats, i.e., alleles with 41 to 100 repeats. Although not methylated, the mRNA of such FMR1 alleles may be altered or alter the binding properties of other proteins. Preliminary results suggest that an increased number of CGG repeats may influence an individual's cognitive and behavioral performance and, for females, affect the age at menopause. If confirmed, this gene may be one of the first clearly identified genes to affect cognitive and behavioral skills and will become one of the possible candidate genes that play a role in psychiatric and behavioral disorders. As the frequency of such FMR1 alleles is high in the population, about 3 percent, the impact on the population may be greater than that related to the mutation leading to the FXS. Moreover, a proportion of these high repeat alleles may be unstably inherited, although that proportion is unknown and factors that influence that instability are not fully understood. In this revised application, the researchers propose to survey a cross-section of the general population and FXS families to obtain a large sample of probands with high repeat alleles. First they will assess all probands with neuropsychological tests to confirm or refute the phenotype consequence of these alleles. Second, they will ascertain parents of probands and conduct a case control study to further examine the relationship between repeat number and the age at menopause in carriers with the high repeat alleles. Lastly, they will ascertain first degree relatives of probands to obtain an estimate of the proportion of unstable alleles in the general population.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD029909-06A1
Application #
6054709
Study Section
Special Emphasis Panel (ZRG1-GNM (02))
Program Officer
Oster-Granite, Mary Lou
Project Start
1994-05-05
Project End
2004-03-31
Budget Start
2000-04-20
Budget End
2001-03-31
Support Year
6
Fiscal Year
2000
Total Cost
$497,321
Indirect Cost
Name
Emory University
Department
Genetics
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Nolin, Sarah L; Sah, Sachin; Glicksman, Anne et al. (2013) Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 161A:771-8
Hunter, Jessica Ezzell; Sherman, Stephanie; Grigsby, Jim et al. (2012) Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology 26:156-64
Hunter, Jessica Ezzell; Leslie, Mary; Novak, Gloria et al. (2012) Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet 159B:549-59
Juncos, Jorge L; Lazarus, Joash T; Rohr, Julia et al. (2012) Olfactory dysfunction in fragile X tremor ataxia syndrome. Mov Disord 27:1556-9
Hunter, Jessica Ezzell; Epstein, Michael P; Tinker, Stuart W et al. (2012) The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet 42:415-22
Visootsak, Jeannie; Charen, Krista; Rohr, Julia et al. (2012) Diagnosis of fragile X syndrome: a qualitative study of African American families. J Genet Couns 21:845-53
Spath, Marian A; Feuth, Ton B; Smits, Arie P T et al. (2011) Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med 13:643-50
Chang, Martin C; DeCaro, John J; Zheng, Mei et al. (2011) Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology 59:1018-23
Allen, Emily Graves; Hunter, Jessica E; Rusin, Michele et al. (2011) Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology 25:404-411
Spath, M A; Feuth, T B; Allen, E G et al. (2011) Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod 26:2185-91

Showing the most recent 10 out of 41 publications